Cargando…
Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004
The guidelines (AWMF register number: 179-004) on neurogenic bowel dysfunction (NBD) in spinal cord injury of the German-speaking Medical Society for Paraplegiology is addressed to all persons who care for people with congenital or acquired paraplegia with NBD. In particular, doctors, nurses and the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484609/ https://www.ncbi.nlm.nih.gov/pubmed/32934429 http://dx.doi.org/10.1007/s00053-020-00482-5 |
_version_ | 1783581005398933504 |
---|---|
author | Geng, Veronika Böthig, Ralf Hildesheim, Andreas Kurze, Ines Leder, Eckhart Dietrich |
author_facet | Geng, Veronika Böthig, Ralf Hildesheim, Andreas Kurze, Ines Leder, Eckhart Dietrich |
author_sort | Geng, Veronika |
collection | PubMed |
description | The guidelines (AWMF register number: 179-004) on neurogenic bowel dysfunction (NBD) in spinal cord injury of the German-speaking Medical Society for Paraplegiology is addressed to all persons who care for people with congenital or acquired paraplegia with NBD. In particular, doctors, nurses and therapists are addressed. The multiprofessionally developed guidelines (involving neurourologists, visceral surgeons, gastroenterologists, health and nursing staff, nutritionists and associated professional societies in the review process) provides practical support for the care of patients with NBD. Definitions and up to date knowledge on the diagnostics of NBD as well as on the necessary conservative bowel management are conveyed in order to ensure the competent treatment of patients with NBD. The concept of NBD and its clinical implications are described. Drug interventions and surgical procedures are explained in brief and recommendations are given. The main objective of the present guidelines is to prevent complications including fecal incontinence and constipation and thus to positively influence the quality of life of those affected. Helpful appendices, which can be used in everyday life, complete the guidelines. |
format | Online Article Text |
id | pubmed-7484609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-74846092020-09-11 Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 Geng, Veronika Böthig, Ralf Hildesheim, Andreas Kurze, Ines Leder, Eckhart Dietrich Coloproctology Leitlinien The guidelines (AWMF register number: 179-004) on neurogenic bowel dysfunction (NBD) in spinal cord injury of the German-speaking Medical Society for Paraplegiology is addressed to all persons who care for people with congenital or acquired paraplegia with NBD. In particular, doctors, nurses and therapists are addressed. The multiprofessionally developed guidelines (involving neurourologists, visceral surgeons, gastroenterologists, health and nursing staff, nutritionists and associated professional societies in the review process) provides practical support for the care of patients with NBD. Definitions and up to date knowledge on the diagnostics of NBD as well as on the necessary conservative bowel management are conveyed in order to ensure the competent treatment of patients with NBD. The concept of NBD and its clinical implications are described. Drug interventions and surgical procedures are explained in brief and recommendations are given. The main objective of the present guidelines is to prevent complications including fecal incontinence and constipation and thus to positively influence the quality of life of those affected. Helpful appendices, which can be used in everyday life, complete the guidelines. Springer Medizin 2020-09-11 2020 /pmc/articles/PMC7484609/ /pubmed/32934429 http://dx.doi.org/10.1007/s00053-020-00482-5 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Leitlinien Geng, Veronika Böthig, Ralf Hildesheim, Andreas Kurze, Ines Leder, Eckhart Dietrich Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 |
title | Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 |
title_full | Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 |
title_fullStr | Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 |
title_full_unstemmed | Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 |
title_short | Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 |
title_sort | leitlinie: neurogene darmfunktionsstörung bei querschnittlähmung (langfassung): entwicklungsstufe: s2k, awmf-register-nr.: 179-004 |
topic | Leitlinien |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484609/ https://www.ncbi.nlm.nih.gov/pubmed/32934429 http://dx.doi.org/10.1007/s00053-020-00482-5 |
work_keys_str_mv | AT gengveronika leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004 AT bothigralf leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004 AT hildesheimandreas leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004 AT kurzeines leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004 AT ledereckhartdietrich leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004 |